CDC recommends Johnson & Johnson to resume using it's COVID-jab


Washington DC
Photo by JUSTIN TALLIS/AFP via Getty Images

The US Centers for Disease Control and Prevention (CDC) recommends Johnson and Johnson resume using its COVID jab, saying its benefit outweighs its side effects.

The CDC advisory committee voted on the vaccine being life-saving,10-4 with an absentee.

The CDC panel met Friday for the second time in less than two weeks to discuss the next steps regarding the use of the Johnson & Johnson vaccine.

There are about 9.5 million doses of the vaccine sitting on shelves across the country that could be deployed immediately, The Hill reported.

So far, 15 cases of clotting syndrome have been confirmed, each of them occurring in women. There were 13 cases in women between the ages of 18 and 49, and the median age of those affected was 37.

The CDC said that Women between 30 and 39 appear to be at the greatest risk, with 11.8 cases per million doses given.

Additional potential causes, including some in men, are currently being reviewed, reported The Hill.

Publish : 2021-04-24 09:46:00

Give Your Comments